HAVCR2 and cancer: As TIM-3 expression marks the terminal differentiation and exhaustion of T-cells and is often co-expressed with other important checkpoint inhibitors such as PD-1 in cancer, TIM-3 expression on CD4+ and CD8+ T cells is considered a cardinal sign of T-cell dysfunctional30.